Dr. Sehra Polad, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 7850 Camargo Rd, Madeira, OH 45243 Phone: 513-271-9700 |
Dr. Andrew Sweeney, PSY.D. Psychologist - Clinical Medicare: Not Enrolled in Medicare Practice Location: 7809 Laurel Ave Ste 2, Madeira, OH 45243 Phone: 513-271-9700 Fax: 513-272-0700 |
News Archive
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
In new report, Sens. Orrin Hatch, R-Utah, and Charles Grassley, R-Iowa, allege the White House's delayed decisions kept health officials from meeting development deadlines for the online exchanges, Reuters reports. Meanwhile, a GAO official tells a Senate panel that the government has a flawed strategy on tech projects.
ACM Global Central Laboratory, the global central lab that continually defines the customer-service standard with its flexible approach, has renewed its College of American Pathologists accreditation for the third time based on the results of a recent onsite inspection.
Cellectis, a clinical-stage biopharmaceutical company focused on developing immunotherapies based on gene-edited CAR T-cells (UCART), today announced the grant by the European Patent Office of patent No. EP3004337 for the invention of using RNA-guided endonucleases, such as Cas9 or Cpf1 for the genetic engineering of T-cells.
› Verified 6 days ago